Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;31(2):75-81.
doi: 10.1016/j.ppedcard.2011.02.002.

Bioenergetics, mitochondria, and cardiac myocyte differentiation

Affiliations

Bioenergetics, mitochondria, and cardiac myocyte differentiation

George A Porter Jr et al. Prog Pediatr Cardiol. 2011 May.

Abstract

Cardiac metabolism is finely tuned, and disruption of myocardial bioenergetics can be clinically devastating. Many cardiomyopathies that present early in life are due to disruption of the maturation of these metabolic pathways. However, this bioenergetic maturation begins well before birth, when the embryonic heart is first beginning to beat, and continues into the mature animal. Thus, the changes in energy production seen after birth are actually part of a continuum that coincides with the structural and functional changes that occur as the cardiac myocyte differentiates and the heart undergoes morphogenesis. Therefore, although bioenergetics and mitochondrial biology have not been studied in great detail in the developing heart, bioenergetic maturation should be considered an important component of normal myocyte differentiation.Although events occurring after birth will be discussed, this review will focus on the changes in bioenergetics and mitochondrial biology that coincide with myocyte differentiation and cardiac morphogenesis. The relationship of these changes to the etiology and presentation of cardiomyopathies will be used as a starting point for this discussion. Then, after reviewing cardiac development and mitochondrial biology, the published data on bioenergetics and mitochondrial structure and function in the developing heart will be presented. Finally, the case will be made that mitochondria may be critical regulators of cardiac myocyte differentiation and cardiac development.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Gross cardiac morphology at different stages of development
Brightfield images of E9.5, E13.5, E18.5, neonatal and adult mouse hearts from roughly the anterior/ventral aspect demonstrate the changes that occur in cardiac morphology during development. Cardiac structures are labeled: Ao—aorta, LA—left atrium, LV—left ventricle, OFT—outflow tract, PA—pulmonary artery, RA—right atrium, and RV—right ventricle. The inset in the lower right corner of the “Adult” heart is the E9.5 heart at the same scale to demonstrate their relative sizes.
Figure 2
Figure 2. Myocardial and myocyte structure during development
Histology (A, hematoxylin and eosin stained, paraffin-embedded sections) and electron micrographs (B, EM) of ventricular myocytes in early embryonic (E9.5), late embryonic (13.5), fetal (E16.5 for Histology, 18.5 for EM), neonatal, and adult hearts demonstrate changes that occur in the general structure of the myocardium and in the composition and structure of the differentiating myocyte. In the “Histology/Late Embryonic” panel, the upper portion represents trabecular myocardium with cross striations, while the lower portion represents the morphology of the compact myocardium. The cardiac lumen (L) is indicated where appropriate.
Figure 3
Figure 3. Mitochondrial structure and function
A. Mitochondria undergo fission and fusion to create a dynamic network that can be fragmented or interconnected, depending on the cell type and the conditions. This example from the same cell demonstrates mitochondrial fission induced by an increase in intracellular calcium. B. Individual mitochondria are complex structures that contain an outer and inner mitochondrial membrane (OMM, IMM), an intermembrane space, and a central matrix. They generate ATP, regulate and are regulated by intracellular calcium levels, and generate reactive oxygen species as well as antioxidants. In an active mitochondrion, electrons enter the electron transport chain (ETC) at complexes I and II and are passed through the Q cycle to complex III, then cytochrome c, and finally to complex IV, where they are used to reduce molecular oxygen to water. The ETC also pumps protons (H+) from the matrix to the intermembrane space, creating an electrochemical gradient (Δψm) that is used by complex V to generate ATP from ADP and inorganic phosphate (Pi). Δψm is represented by the negative charges in the mitochondrial matrix and is responsible for the influx of calcium (Ca2+) through various channels, whose composition is not completely known. Finally, complexes I and II are also responsible for the creation of superoxide anions (O2•−) that are converted by Mn-superoxide dismutase (SOD) to H2O2, which can diffuse into the sarcoplasm.
Figure 4
Figure 4. Mitochondrial network morphology in cultured myocytes
Fluorescence imaging of mitochondria in cardiac myocytes from E9.5, E13.5, and adult hearts demonstrates dramatic changes in the structure of the mitochondrial network as the heart develops. E9.5 myocytes have a fragmented network, while the mitochondria in E13.5 myocytes are more filamentous and spread throughout the cell. In contrast, the mitochondria network in the adult myocyte is highly structured, with mitochondria aligning in specific bands along the myofibrils and in the perinuclear and subsarcolemmal regions. Primary myocyte cultures were labeled with MitoTracker Green and imaged using epifluorescence (E9.5, E13.5) or confocal (Adult) microscopy.

Similar articles

Cited by

References

    1. Conway SJ, Kruzynska-Frejtag A, Kneer PL, Machnicki M, Koushik SV. What cardiovascular defect does my prenatal mouse mutant have, and why? Genesis. 2003;35:1–21. - PubMed
    1. Turgeon B, Meloche S. Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases. Physiol Rev. 2009;89:1–26. - PubMed
    1. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–55. - PubMed
    1. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–46. - PubMed
    1. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913–19. - PubMed

LinkOut - more resources